Timing matters: Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.
Original Source:
https://www.foxnews.com/health/hidden-factor-cancer-treatment-timing-may-affect-survival-researchers-say
